29 January – Monday

08:30 Registration
08:45 Opening Remarks and Welcome Address
09:00 SESSION: IO & PRACTICE GUIDELINES

  • Single HCC < 3cm: RFA or MWA?
    RFA
    MWA
    Discussant/Summing up
  • Single HCC > 3 cm: MWA or Combined Treatment?
    MWA
    Combined Treatment
    Discussant/Summing up
  • Multinodular HCC/Intermediate Stage: TACE or TARE?
    TACE
    TARE
    Discussant/Summing up
  • HCC & PVT: Medical Therapy or TARE?
    Medical Therapy
    TARE
    Discussant/Summing up
10:30 EXPERT PANEL DISCUSSION: Early Stage HCC
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION
11:10 The “7 DEADLY SINS & 7 VIRTUES”: Percutaneous Devices
11:30 Coffee Break
11:45 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
12:40 BE INNOVATIVE, SHARE YOUR EXPERIENCE
Oral Communication: Preclinical Data
13:00 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
13:30 LUNCH SYMPOSIUM
15:15 SESSION: IO & Technological-Economical Issues
Live Cases (Treatment Strategies based on “Expert Panel Discussion”)

  • Planning & Guidance Software for percutaneous hepatic treatments
  • Laparoscopic Ablation for liver lesions: when and why?
  • Trans-radial Intra-arterial Approach for Hepatic Treatments: how, when, and why?
  • Radiation Oncology for liver disease: where are we going?
  • Economical Sustainability: is IO worth the investment?
16:45 Coffee Break
17:00 EXPERT PANEL DISCUSSION: Intermediate-Stage HCC
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION
17:40 The “7 DEADLY SINS & 7 VIRTUES”: Catheter/Microcatheter
18:15 Plenary Discussion on patients treated

 

30 January – Tuesday

08:30 SESSION: IO & Evidence-Based Practice
Live Cases (Treatment Strategies based on “Expert Panel Discussion”)

  • mCRC & Medical Treatments: where are we going?
  • mCRC & Percutaneous Options: what’s new?
  • mCRC & Intra-arterial Options: which evidences?
  • Question Time: oncologist point of view
10:00 EXPERT PANEL DISCUSSION: Advanced-Stage HCC
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION
10:30 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
11:00 Coffee Break
11:40 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
12:00 The “7 DEADLY SINS & 7 VIRTUES”: Embolic Agents
12:15 BE INNOVATIVE, SHARE YOUR EXPERIENCE
ORAL COMMUNICATION: New Devices/Techniques
13:30 LUNCH
15:00 SESSION: IO & Pancreatic Tumors
Live Cases (Treatment Strategies based on “Expert Panel Discussion”)

  • Medical Treatments: where are we going?
  • Surgical Option: when is it unresectable?
  • Endoscopic Approach: current and future prospectives
  • Radiation Oncology: current and future prospectives
  • Interventional Oncology: current and future prospectives
  • Interventional Oncology: which role for IRE?
17:00 BE INNOVATIVE, SHARE YOUR EXPERIENCE
ORAL COMMUNICATION: (Morbidity/Mortality)
17:30 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
18:00 Plenary Discussion on patients treated
18:15 End